NEULANDLAB.NSライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 17:54):

Stats
本日の出来高	7 437.00
平均出来高	45 692.00
時価総額	95.64B
EPS	INR0 ( 2024-02-08 )
次の収益日	( INR0 ) 2024-05-09
Last Dividend	INR10.00 ( 2023-07-11 )
Next Dividend	INR0 ( N/A )
P/E	30.15
ATR14	INR4.50 (0.06%)

ボリューム相関

長: 0.17 (neutral)

短: 0.39 (neutral)

Signal:(49.316) Neutral

Neuland Laboratories 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Neuland Laboratories 相関 - 通貨/商品

-0.26
( neutral )

-0.36
( neutral )

0.02
( neutral )

-0.24
( neutral )

-0.01
( neutral )

-0.07
( neutral )

Neuland Laboratories 財務諸表

Annual	2022
収益:	INR11.91B
総利益:	INR5.77B (48.47 %)
EPS:	INR127.45

FY	2022
収益:	INR11.91B
総利益:	INR5.77B (48.47 %)
EPS:	INR127.45

FY	2022
収益:	INR9.25B
総利益:	INR3.72B (40.18 %)
EPS:	INR49.74

FY	2021
収益:	INR9.24B
総利益:	INR3.66B (39.55 %)
EPS:	INR62.85

Financial Reports:

No articles found.

Neuland Laboratories Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR5.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR10.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Neuland Laboratories Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.32 - low (10.63%) | Divividend Growth Potential Score: 3.73 - Decrease likely (25.46%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR2.90	2009-07-13
Last Dividend	INR10.00	2023-07-11
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	11	--
Total Paid Out	INR32.18	--
Avg. Dividend % Per Year	0.33%	--
Score	1.8	--
Div. Sustainability Score	3.32
Div.Growth Potential Score	3.73
Div. Directional Score	3.52	--

Next Divdend (Est)
(2025-01-24)

INR12.33 Estimate 2.94 %

Dividend Stability

0.24 Very Poor

Dividend Score

1.80

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0	0.00%
2019	INR1.200	0.25%
2020	INR4.00	0.96%
2021	INR3.00	0.28%
2022	INR5.00	0.32%
2023	INR10.00	0.60%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SMSPHARMA.NS	Ex Dividend Junior	2023-09-22	Annually	18	0.12%
MINDTECK.NS	Dividend Junior	2023-08-04	Sporadic	8	0.28%
HBSL.NS	Dividend Junior	2023-08-11	Sporadic	12	0.78%
BEPL.NS	Dividend King	2023-07-25	Semi-Annually	20	4.91%
RADICO.NS	Dividend Junior	2023-09-14	Annually	22	0.24%
KHAICHEM.NS	No Dividend Player	2023-07-21	Annually	5	0.32%
EMAMIPAP.NS	Dividend Junior	2023-09-05	Annually	3	0.56%
AJANTPHARM.NS	Dividend Knight	2023-08-04	Annually	23	0.57%
SUNTV.NS	Dividend Knight	2023-08-22	Quarterly	19	1.94%
NAVNETEDUL.NS	Dividend Junior	2023-08-07	Annually	22	1.10%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.201	1.500	5.99	8.98	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.298	1.500	7.80	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	29.44	1.000	0.209	0.209	[3 - 30]
operatingCashFlowPerShareTTM	88.40	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	88.40	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.518	1.000	4.71	4.71	[0.2 - 0.8]
operatingProfitMarginTTM	0.273	1.000	6.53	6.53	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.32

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	29.92	1.000	7.08	0	[1 - 100]
returnOnEquityTTM	0.298	2.50	8.58	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	88.40	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.135	1.500	6.62	0	[0 - 0.4]
operatingCashFlowPerShareTTM	88.40	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.403	1.500	-6.02	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0718	1.000	-0.706	0	[0.1 - 0.5]
Total Score				3.73

Neuland Laboratories

Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was incorporated in 1984 and is headquartered in Hyderabad, India.

リアルタイムの更新： Neuland Laboratories [NEULANDLAB.NS]

Upcoming Earnings Alert

Neuland Laboratories Dividend Information - Dividend Junior

Dividend Commentary

Top 10 dividend Companies for NSE

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)